Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
CHRM3 Biologics Sequence Review Report 2026: Muscarinic acetylcholine receptor M3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRM3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRM2 Biologics Sequence Review Report 2026: Muscarinic acetylcholine receptor M2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRM2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRM5 Biologics Sequence Review Report 2026: Muscarinic acetylcholine receptor M5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRM4 Biologics Sequence Review Report 2026: Muscarinic acetylcholine receptor M4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRM4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR5 Biologics Sequence Review Report 2026: Complement factor H-related protein 5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR4 Biologics Sequence Review Report 2026: Complement factor H-related protein 4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR3 Biologics Sequence Review Report 2026: Complement factor H-related protein 3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRM1 Biologics Sequence Review Report 2026: Muscarinic acetylcholine receptor M1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR2 Biologics Sequence Review Report 2026: Complement factor H-related protein 2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CFHR1 Biologics Sequence Review Report 2026: Complement factor H-related protein 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CFHR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CEACAM8 Biologics Sequence Review Report 2026: Cell adhesion molecule CEACAM8 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CEACAM8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CENPB Biologics Sequence Review Report 2026: Major centromere autoantigen B Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CENPB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
66
67
68
69
70
>>
1103
>